Dermatological adverse events with taxane chemotherapy
V. Sibaud1, Nicole R. LeBoeuf2, Henri Roché3, Viswanath Reddy Belum4, Laurence Gladieff3, Marion Deslandres3, Marion Montastruc3, Audrey Eche3, Émmanuelle Vigarios5, Florence Dalenc3, Mario E. Lacouture4
1Departments of Oncodermatology and Clinical Research, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, France.
2Dana-Farber/Brigham & Women’s Cancer Center, Harvard Medical School
3Department of Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, France.
4Memorial-Sloan Kettering Cancer Center
5Department of Oral Medicine, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, France.